Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · IEX Real-Time Price · USD
0.626
+0.034 (5.74%)
Jun 20, 2024, 2:17 PM EDT - Market open

Sensei Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018
Market Capitalization
151746177--
Upgrade
Market Cap Growth
--62.21%-74.21%---
Upgrade
Enterprise Value
-38-42-5332-1615
Upgrade
PE Ratio
-0.82-0.51-0.94-4.82--
Upgrade
PB Ratio
0.250.270.441.21--
Upgrade
P/FCF Ratio
-0.95-0.54-1.16-5.55--
Upgrade
P/OCF Ratio
-0.94-0.54-1.17-5.86--
Upgrade
EV/EBITDA Ratio
0.901.351.16-0.910.87-1.07
Upgrade
EV/EBIT Ratio
0.821.241.10-0.890.86-1.06
Upgrade
EV/FCF Ratio
0.941.321.36-1.010.84-1.78
Upgrade
Debt / Equity Ratio
0.100.100.080.02-0.01-0.23
Upgrade
Debt / EBITDA Ratio
-0.19-0.20-0.18-0.07-0.04-1.11
Upgrade
Debt / FCF Ratio
-0.20-0.19-0.20-0.07-0.04-1.86
Upgrade
Quick Ratio
11.6311.6511.8230.193.440.03
Upgrade
Current Ratio
12.0711.9211.9830.384.160.02
Upgrade
Interest Coverage
-244.51-235.81-220.86-53.92-10.90-6.42
Upgrade
Return on Equity (ROE)
-46.70%-44.00%-40.60%-23.10%32.30%33.60%
Upgrade
Return on Assets (ROA)
-40.90%-38.60%-36.30%-22.40%-178.40%-1339.70%
Upgrade
Return on Capital (ROIC)
-54.26%-52.13%-45.04%-25.18%34.88%23.64%
Upgrade
Earnings Yield
-214.95%-197.14%-106.15%-20.73%--
Upgrade
FCF Yield
-187.31%-185.21%-85.93%-18.01%--
Upgrade
Buyback Yield / Dilution
18.85%8.96%-10.80%-1618.88%-338.85%97.92%
Upgrade
Total Shareholder Return
18.85%8.96%-10.80%-1618.88%-338.85%97.92%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).